BioCentury
ARTICLE | Clinical News

D-99 liposomal doxorubicin: Will start Phase III

September 26, 1994 7:00 AM UTC

The Liposome Co. Inc. (LIPO), Princeton, N.J. Product: D-99 liposomal doxorubicin Status: Will start Phase III studies in the fourth quarter ...